ClinVar Miner

Submissions for variant NM_000038.6(APC):c.5102_5104del (p.Gln1701_Gly1702delinsArg)

gnomAD frequency: 0.00001  dbSNP: rs1554086446
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Color Diagnostics, LLC DBA Color Health RCV000579858 SCV000681707 uncertain significance Hereditary cancer-predisposing syndrome 2023-06-27 criteria provided, single submitter clinical testing This variant causes a deletion of three nucleotides located in exon 16 of the APC gene, replacing two amino acids Glutamine and Glycine with an Arginine. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with APC-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Labcorp Genetics (formerly Invitae), Labcorp RCV004562529 SCV002196440 uncertain significance Familial adenomatous polyposis 1 2024-09-23 criteria provided, single submitter clinical testing This variant, c.5102_5104del, is a complex sequence change that results in the deletion of 2 and insertion of 1 amino acid(s) in the APC protein (p.Gln1701_Gly1702delinsArg). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with APC-related conditions. ClinVar contains an entry for this variant (Variation ID: 489464). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV000579858 SCV002645813 uncertain significance Hereditary cancer-predisposing syndrome 2023-11-29 criteria provided, single submitter clinical testing The c.5102_5104delAAG variant (also known as p.Q1701_G1702delinsR) is located in coding exon 15 of the APC gene. This variant results from an in-frame AAG deletion at nucleotide positions 5102 to 5104. The amino acids at codons 1701 and 1702 are deleted and replaced by an arginine. These amino acid positions are not well conserved in available vertebrate species. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
All of Us Research Program, National Institutes of Health RCV004001228 SCV004838003 uncertain significance Classic or attenuated familial adenomatous polyposis 2024-02-05 criteria provided, single submitter clinical testing This variant causes a deletion of three nucleotides located in exon 16 of the APC gene, replacing two amino acids Glutamine and Glycine with an Arginine. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with APC-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
GeneDx RCV004722950 SCV005334314 uncertain significance not provided 2023-12-23 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In-frame deletion of two amino acids and the insertion of one in a non-repeat region; In silico analysis supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 18199528)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.